Adjuvant Treatment with Alpha Interferon (IFN) for Patients at High Risk for Relapse after Allogeneic Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

被引：1
|
作者：
Bezerra, Evandro Dantas [1 ]
Radich, Jerald [2 ]
Flowers, Mary E. [2 ]
Chielins, Debbie [3 ]
Higano, Celestia [4 ]
机构：
[1] Univ Washington, Med, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[3] Seattle Canc Care Alliance, Oncol, Seattle, WA USA
[4] Univ Washington, Dept Med, Seattle, WA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期
关键词：
D O I：
10.1016/j.bbmt.2017.12.224
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
326
引用
收藏
页码：S238 / S238
页数：1
相关论文
共 50 条
  • [1] Adjuvant treatment with alfa interferon (IFN) for patients at high risk for relapse after allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML): A preliminary report.
    Higano, C
    Chielens, D
    Radich, J
    Flowers, M
    Appelbaum, F
    BLOOD, 1998, 92 (10) : 654A - 654A
  • [2] ALPHA-INTERFERON (IFN) RESULTS IN HIGH COMPLETE CYTOGENETIC RESPONSE RATE IN PATIENTS WITH CYTOGENETIC-ONLY RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER MARROW TRANSPLANTATION (BMT)
    HIGANO, C
    RASKIND, W
    FLOWERS, M
    BLOOD, 1993, 82 (10) : A169 - A169
  • [3] Absence of influence of prior interferon alfa (IFN alpha) therapy on the outcome of allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML).
    Tomas, IF
    Steegman, IL
    Requena, MI
    Soria, VGG
    FernandezRanada, IM
    BLOOD, 1995, 86 (10) : 3859 - 3859
  • [4] Autologous BMT transplantation for the treatment of interferon-resistant chronic myelogenous leukemia (CML).
    Muth, A
    Chen, ZZ
    Öttrich, K
    Humann, M
    Ledderose, G
    Kolb, HJ
    BONE MARROW TRANSPLANTATION, 1999, 23 : S61 - S61
  • [5] USE OF ALPHA-INTERFERON FOR THE TREATMENT OF RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    HIGANO, CS
    RASKIND, WH
    SINGER, JW
    BLOOD, 1992, 80 (06) : 1437 - 1442
  • [6] Treatment of patients with multiply myeloma (MM) and chronic myelogenous leukemia (CML) with alpha-2 interferon (IFN).
    Bessmeltsev, SS
    Rukavitsyn, OA
    Abdulkadyrov, KM
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 711 - 711
  • [7] Improved survival of patients with chronic myelogenous leukemia (CML) undergoing allogeneic bone marrow transplantation (BMT).
    Moreb, J
    Johnson, T
    Kubilis, P
    Myers, L
    BLOOD, 1995, 86 (10) : 3826 - 3826
  • [8] Sequential cladribine and interferon-alpha (IFN) in chronic myelogenous leukemia (CML).
    Saven, A
    Burian, C
    Kosty, M
    Mason, J
    Douer, D
    BLOOD, 1999, 94 (10) : 279B - 279B
  • [9] Pilot study of interferon alpha receptor (IFN alpha R) expression in patients with chronic myelogenous leukemia (CML).
    Spielberger, R
    Snyder, D
    Forman, SJ
    Niland, J
    Nunez, R
    Domanski, PI
    Colamonici, O
    BLOOD, 1995, 86 (10) : 2100 - 2100
  • [10] ALLOGENEIC MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA (CML)
    BUCKNER, CD
    CLIFT, RA
    STORB, R
    THOMAS, ED
    EXPERIMENTAL HEMATOLOGY, 1986, 14 (06) : 486 - 486
12345